-
Liber Pharmaceuticals’ statement on ingredient safety and device design of its Nicovape Q products
- March 10, 2026
- Posted by: Kelvin Antonio
- Category: Company updates
No Comments -
TGO 110 compliant Nicovape Q stock is now available to order via API, Sigma and Symbion
- November 7, 2025
- Posted by: itadmin
- Category: Company updates
-
Temporary Hold On Supply Of Nicovape Q SKUs
- October 10, 2025
- Posted by: itadmin
- Category: Company updates
-
Product Notice – s14A Consent Granted (TGO 110)
- July 15, 2025
- Posted by: Liber
- Category: Company updates
-
Transition to Nicovape® Q2 System Complete
- January 9, 2025
- Posted by: Liber
- Category: Company updates
Liber Pharmaceuticals has now discontinued its Nicovape® Q A1 device and associated Nicovape® Q | QSD cartridge SKUs, and completed transitioning all users to the new Nicovape® Q2 system.
-
GP’s seek help in understanding how to prescribe e-cigarettes to smokers
- October 1, 2021
- Posted by: Liber
- Categories: Australian news & media, Company updates, Press releases
More than two thousand GP’s have already requested access to a guide created to provide clarity around Australia’s new vaping landscape, and their role in assisting patients who wish to quit smoking.
